S. Korea's Celltrion to start phase 1 test vaccine testing on patients with COVID symptoms

S. Korea's Celltrion to start phase 1 test vaccine testing on patients with COVID symptomsПодробнее

S. Korea approves Celltrion's antibody COVID-19 treatmentПодробнее

U.S. FDA approves S. Korea's Celltrion COVID-19 test kitПодробнее

Celltrion accelerates development of COVID-19 treatment, aims for clinical test in late JulyПодробнее

S. Korea grants approval for locally-developed COVID-19 antibody treatmentПодробнее

COVID-19 treatment made by S. Korea's Celltrion under reviewПодробнее

S. Korea's Celltrion COVID-19 antibody drug ready for useПодробнее

Celltrion's COVID-19 treatment gets conditional approval for medium and high-risk patientsПодробнее

INO-4800 vaccine starts clinical trials in S. Korea -- WHO expert explains how it worksПодробнее

S. Korea's drug ministry approves clinical trials of COVID-19 vaccine, treatmentПодробнее

S. Korea finds only 1 case of COVID-19 antibodies out of 3,000 testedПодробнее

[LIVE] 🔊 S. KOREAN GOV'T BRIEFING ON COVID-19 | VACCINES AND TREATMENTПодробнее

Celltrion's inhaled COVID-19 treatment undergoes phase 1 clinical trial in AustraliaПодробнее

Celltrion’s COVID-19 Antiviral Set for Phase I Human Clinical TrialПодробнее

S. Korea to mass-produce antibody treatment of COVID-19 this monthПодробнее

Celltrion's COVID-19 treatment can reduce recovery time, decrease rate of being severely ill by 54%Подробнее

[FULL] THE DAILY REPORT : S. Korea's critical COVID-19 patients at record levels for 3rd ...Подробнее

S. Korean gov't announces plans to support COVID-19 vaccine developmentПодробнее

The COVID 19 pandemic: testing – serological diagnostics for COVID 19Подробнее

S. Korea to begin producing plasma treatment for COVID-19 clinical trialsПодробнее